Barclays analyst Luke Sergott reiterated an Overweight rating and $45.00 price target on Twist Bioscience (NASDAQ: TWST)The analyst comments "Management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE